Platelet function and inhibition in ischemic heart disease.

Current Cardiology Reports
Annunziata Nusca, Giuseppe Patti

Abstract

Platelets play an important role in the pathogenesis of thrombosis, the most common cause for the development of acute coronary syndromes such as complications occurring during percutaneous coronary intervention. Platelets act with a multiple step mechanism, in which different surface molecules are involved representing important therapeutic targets of antiplatelet agents. Despite clopidogrel efficacy which has been demonstrated in several studies, recurrent ischemic events remain considerably high in patients on treatment due to low clopidogrel responsiveness, a phenomenon influenced by environmental, clinical, and genetic factors. New P2Y12 blockers such as prasugrel and ticagrelor have been successfully introduced in clinical practice, whereas cangrelor, with a rapid offset and reversible platelet inhibition, may represent a useful bridging therapy in patients undergoing surgery. Moreover, the simultaneous inhibition of thrombin platelet aggregation by protease-activated receptor inhibitors may be an adjunctive approach in patients with coronary artery disease.

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Oct 21, 2004·JAMA : the Journal of the American Medical Association·Huyen Tran, Sonia S Anand
Nov 16, 2005·Journal of the American College of Cardiology·Paul A GurbelUdaya S Tantry
Jan 28, 2006·Mayo Clinic Proceedings·David A Vorchheimer, Richard Becker
Aug 16, 2006·Circulation·John W EikelboomSalim Yusuf
Sep 28, 2006·Journal of Thrombosis and Haemostasis : JTH·I FuchsB Jilma
Apr 10, 2007·Journal of the American College of Cardiology·Dominick J AngiolilloMarco A Costa
Jun 19, 2007·Journal of the American College of Cardiology·Piergiovanni BuonamiciDavid Antoniucci
Oct 9, 2007·The American Journal of Cardiology·Marzia LotrionteImad Sheiban
Oct 16, 2007·Journal of the American College of Cardiology·Dominick J AngiolilloAntonio Fernandez-Ortiz
Nov 6, 2007·Journal of the American College of Cardiology·Paul A GurbelAlan D Michelson
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Dec 14, 2007·The New England Journal of Medicine·Giovanni Davì, Carlo Patrono
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Feb 14, 2009·The American Journal of Cardiology·Alan D Michelson
Apr 3, 2009·Cleveland Clinic Journal of Medicine·Kandice Kottke-Marchant
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Nov 17, 2009·The New England Journal of Medicine·Robert A HarringtonDeepak L Bhatt
Nov 17, 2009·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHAMPION PLATFORM Investigators
Dec 1, 2009·Journal of Thrombosis and Haemostasis : JTH·D SibbingA Kastrati
Jul 31, 2010·Expert Review of Cardiovascular Therapy·Masafumi UenoDominick J Angiolillo
Aug 31, 2010·European Heart Journal·UNKNOWN Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardDavid Taggart

❮ Previous
Next ❯

Citations

Oct 8, 2013·European Journal of Medicinal Chemistry·Esteban Durán-LaraLeonardo S Santos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cardiovascular Translational Research
Annunziata NuscaGermano Di Sciascio
Expert Review of Cardiovascular Therapy
José Luis FerreiroDominick J Angiolillo
Journal of Cardiovascular Translational Research
Flavio de Souza Brito, Pierluigi Tricoci
American Heart Journal
Dominick J Angiolillo, Luis A Guzman
© 2021 Meta ULC. All rights reserved